New Opportunities
- PhRMA Foundation Fellowship applications are now open.
- Drug Discovery, Drug Delivery and Translational Medicine: For the first time in its 60-year history, the PhRMA Foundation is opening a second funding cycle in the same calendar year to support additional predoctoral and postdoctoral researchers in 2027. The Foundation is currently accepting letters of intent (LOIs) from PhD students and postdocs conducting research in drug discovery, drug delivery, and translational medicine. The LOI deadline is October 30, 2026, at 12:00 p.m.
- Value Assessment & Health Outcomes Research: The application is also open for the PhRMA Foundation Fellowships to support early-career researchers who investigate challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions. Proposals must include meaningful and authentic engagement with patients, caregivers, or clinicians. A recording of an informational session about the fellowships is available on the PhRMA Foundation website. The application deadline is October 30, 2026 at 12:00 p.m. ET.
- Predoctoral Fellowships will provide up to $30,000 a year for 2 years. Applicants must be full-time, in-residence students at accredited U.S. universities who have completed all qualifying exams by the time of submission and who have at least one publication or poster presentation.
- Postdoctoral Fellowships will provide up to $60,000 a year for 2 years. Applicants must be based at an accredited, doctoral degree-granting university in the U.S., hold a PhD, PharmD, MD or terminal research doctorate granted no earlier than January 1, 2024 and have at least two first author publications.
- American Heart Association Career Development Award: This award supports healthcare and academic professionals early in their first professional appointment, to assure future success in the field of cardiovascular and/or cerebrovascular disease research. Proposals are due Tuesday, December 1, 2026
- American Heart Association Innovative Project Award: This award funds highly innovative, high-impact research and promotes unexplored ideas; preliminary data is not required and not accepted as part of the proposal. The principal investigator must hold a PhD or equivalent degree or doctoral-level clinical degree, e.g., MD, DO, DVM, PharmD. Proposals are due Wednesday, December 9, 2026.
Federal Agencies
Please regularly visit the following websites and directly search for funding opportunities and deadlines in your research field.
Explore NIH Funding: A search tool to filter funding opportunities on Grants.gov by NIH/HHS-specific categories like funding category, funding organization (e.g., NCI, NCATS) and keyword. NIH funding opportunities are now exclusively posted to Grants.gov.
Notices of Funding Opportunity of particular interest for pharmacy include:
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional): "The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (hereafter referred to as evidence-based interventions). Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters (e.g., pandemics, climate change) remain relevant." Upcoming application due dates: February 5, 2027, June 5, 2027 and October 5, 2027
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional): Upcoming application due dates: February 16, 2027, June 16, 2027 and October 16, 2027
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed): Upcoming application due dates: Upcoming application due dates: February 16, 2027, June 16, 2027 and October 16, 2027
- Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed), PAR-27-069: This opportunity allows eligible investigators to access biospecimens from the All of Us Biobank through Partnered Research Studies and to return newly generated data to the All of Us Researcher Workbench. No funds are associated with awards from this announcement. You can learn more about the opportunity here. Application due dates: October 30, 2026 and March 1, 2027
- The Medical Scientist Training Program (MSTP) T32: "The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of well-trained clinician-scientist leaders available to address the nation’s biomedical research needs. Specifically, this funding announcement provides support to eligible, domestic organizations to develop and implement effective, evidence-informed approaches to dual-degree training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise and lead to the completion of both a clinical degree (for example, M.D., D.O., D.V.M., D.D.S., Pharm.D., etc.) and a research doctorate degree (Ph.D.)."
- NIH Loan Repayment Programs: The NIH Loan Repayment Programs (LRP) were established by Congress to recruit and retain health professionals in biomedical and behavioral research careers. The LRPs repay up to $50,000 annually of a researchers qualified educational debt "in return for a commitment to engage in NIH mission-relevant research." Research subcategories include LRP award subcategories include clinical research, pediatric research, and Facilitating Opportunities in Cutting-edge Science (FOCUS). More information is available on the Extramural LRP application page. The LRP application period closes on November 19, 2026.
- Biomedical Research Environment & Sponsored Programs Administration Development (BRE-SPAD) Program: BRE-SPAD supports resource-limited institutions with few to no biomedical research doctoral students to conduct research, enhance their research environments, and increase sponsored programs administration capacity. Applicants should propose plans in at least two of the following funding areas: Sponsored Programs Administration Development, Research Environment, Pilot Research Project Program. The next application due date is January 27, 2027.
NIH Highlighted Topics: A resource to help researchers identify research priority areas for NIH Institutes, Centers, and Offices. Investigators interested in a topic should apply through an appropriate funding opportunity, such as the NIH R01 Parent Funding Announcement (clinical trial not allowed) or other broad NIH opportunities on Grants.gov. Highlighted topics may or may not have dedicated funding.
Topics of potential interest for pharmacy include:
- Model-Informed Drug Development (MIDD) to Advance Pharmacotherapeutics: This topic expires on October 23, 2028.
- Food Is Medicine: This topic expires on June 3, 2028
- Advancing the Science of Prenatal Dietary Supplements: This topic expires on May 21, 2028
- New Approach Methodologies (NAMs) for Dietary Supplement and Nutrition research: This topic expires on May 20, 2028
- Training and Career Development in Dissemination and Implementation (D&I) Science: This topic expires on April 14, 2027
- GLP-1s: Implications for Nutritional Status and Metabolic Health Outcomes: This topic expires on April 24, 2027.
- Implementation Science to Optimize HIV Prevention and Treatment: This topic expires on December 2, 2026.
- Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options: This topic expires on March 10, 2027.
- Drug Discovery for Nervous System Disorders: This topic expires on January 28, 2027.
NSF Funding: The Foundation supports basic research and education in most fields, including biological, chemical, environmental, social, behavioral and economical sciences, collaborative research between universities and industry, and graduate and postdoctoral fellowships.
Open funding opportunities of interest include:
- NSF Engineering Biological and Biomedical Systems: Supported areas of inquiry include mechanistic studies of microbial population and cell behavior and of therapeutic cells and tissues; studies of the underlying engineering principles of biological systems and bioreactors; the creation of novel biosensing platforms and new optical imaging and modulation strategies; the design of biological sensing systems; and studies of tissue changes injury or repair. The NOFO does not support proposals with a main goal of drug design, drug delivery, or the development of animal models of disease. Full proposals to the solicitation are accepted anytime.
CDC Funding: Supports research to keep Americans safe and healthy both domestically and abroad.
USDA NIFA Grants: Supports research and fellowships on nutrition and health, education, environment, biotechnology and genomics, economics and community development.
AHRQ Funding & Grants: Supports research to improve the quality, safety, efficiency, and effectiveness of healthcare for all Americans. AHRQ currently does not have any open funding opportunities.
DOD Grants: The Department of Defense (DOD) Office of Congressionally Directed Medical Research Programs (CDMRP) supports biomedical research across the development pipeline from basic to clinical through annual funding opportunities.
Additional Organizations, Associations and Foundations
Proposal Central Provides access to funding opportunities funders including the Alzheimer’s Association, American Association for Cancer Research, Burroughs Wellcome Fund, and many others
- American Heart Association Career Development Award: This award supports healthcare and academic professionals early in their first professional appointment, to assure future success in the field of cardiovascular and/or cerebrovascular disease research. Proposals are due Tuesday, December 1, 2026
- American Heart Association Innovative Project Award: This award funds highly innovative, high-impact research and promotes unexplored ideas; preliminary data is not required and not accepted as part of the proposal. The principal investigator must hold a PhD or equivalent degree or doctoral-level clinical degree, e.g., MD, DO, DVM, PharmD. Proposals are due Wednesday, December 9, 2026
American Brain Tumor Association
American Respiratory Care Foundation
International Rett Syndrome Foundation
National Pharmaceutical Council
Patient-Centered Outcomes Research Institute
- PhRMA Foundation 2027 Fellowships Value Assessment & Health Outcomes Research: These fellowships support early-career researchers who investigate challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions. Proposals must include meaningful and authentic engagement with patients, caregivers, or clinicians. A recording of an informational session about the fellowships is available on the PhRMA Foundation website. The application deadline is October 30, 2026 at 12:00 p.m. ET.
- Predoctoral Fellowships will provide up to $30,000 a year for 2 years. Applicants must be full-time, in-residence students at accredited U.S. universities who have completed all qualifying exams by the time of submission and who have at least one publication or poster presentation.
- Postdoctoral Fellowships will provide up to $60,000 a year for 2 years. Applicants must be based at an accredited, doctoral degree-granting university in the U.S., hold a PhD, PharmD, MD or terminal research doctorate granted no earlier than January 1, 2024 and have at least two first author publications.